SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 26 Sept · 13:13 IST

Shilpa Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shilpa Medicare Limited has informed the exchanges that the trading window for its securities will be closed for all designated persons and their immediate relatives starting 1 October 2025. The window will reopen 48 hours after the company declares its un-audited financial results for the quarter and half year ended 30 September 2025. This is a standard compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015, aimed at preventing insider trading ahead of results. The date of the board meeting to consider the Q2/H1 FY26 financial results has not been announced yet and will be communicated separately.

Likely market impact

This is a routine regulatory filing with no direct impact on shareholders or the stock price. It signals that the company's Q2 and half-yearly financial results announcement is approaching, which investors should watch for as the next potential catalyst.